VIDEO: Chemotherapy Foundation Symposium a ‘fantastic’ meeting

ByCharu Aggarwal, MD, MPH

ByMarley V. Ghizzone

In this video, Charu Aggarwal, MD, MPH, discusses presentations in both non-small cell and small cell lung cancer from Chemotherapy Foundation Symposium.

“Overall, fantastic meeting, terrific audience and great enthusiasm,” said Aggarwal, Leslye M. Heisler assistant professor for lung cancer excellence at University of Pennsylvania Abramson Cancer Center.

References:

Brahmer JR. Competing Frontline Immunotherapy Strategies in Lung Adenocarcinoma. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Bazhenova L. New Therapies for Emerging Targets (KRAS, G12C, HER2, BRAF, MET). Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Drilon AE. Targeting Gene Fusions in Adenocarcinoma (ALK, ROS1, RET, NTRK). Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Halmos B, et al. Updates in the Management of Squamous Cell Lung Cancer. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Kris G. Precision Medicine in Early-Stage Lung Cancer. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Levy BP, et al. Medical Crossfire: Adjuvant Targeted or Immune Therapy—Ready for Prime Time? Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Liu SV. Novel Therapeutic Strategies for Small Cell Lung Cancer. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.
Piotrowska Z. Evolving Treatment Strategies for EGFR-Mutated Lung Cancer, Including Exon 20. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.

Published by:

Sources/Disclosures

Collapse

Source: Healio Interview

Disclosures: Aggarwal reports consulting for AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech and Merck.

Take Homes in Lung Cancer

Read more

VIDEO: Chemotherapy Foundation Symposium a ‘fantastic’ meeting

References:

Related Content